NEW ENANTIOMERICALLY PURE PHOSPHORIC ACIDS
371
3
by the addition of TEA (1.5 mmol) and H2O (5.5 mmol) (125 MHz, CDCl3): d 5 142.4 (d, JC-P 5 11 Hz, C aryl-
3
and allowed to stir for an additional hour. The pale yellow CH), 141.2 (d, JC-P 5 11 Hz, C aryl0-CH0), 138.3 (2 C, 2,20-
solution was diluted with AcOEt/H2O (ca. 6 ml) and the C), 138.1 (6-C), 137.3 (10-C), 136.6 (60-C), 135.74 (1-C), 132
2
layers were separated. The aqueous layer was then (5-C), 131.9 (q, JC-F 5 32 Hz, 2 C, m-aryl C), 131.4 (50-C),
2
extracted 3 3 AcOEt (5 ml). The combined organic 131.3 (q, JC-F 5 32 Hz, 2 C, m0-aryl C), 129.2 (4-C), 129.1
phases were dried with Na2SO4, filtered, and the solvent (40-C), 128.5 (3-C), 126.6 (30-C), 126.1 (2 C, o0-aryl C), 125.6
1
was removed in vacuo. Flash chromatography (n-Hexane/ (2 C, o-aryl C), 123 (q, JC-F 5 250 Hz, 4 C, CF3, C0F3),
AcOEt) afforded the product.
121.8 (p0-aryl C), 121.4 (p-aryl C), 80.7 (CHOP), 73.6
(C0HOP0), 19.5 (2-CH3), 18.3 (20-CH3) ppm. 31P NMR
1
Phosphite (3). The general procedure was followed
to provide the title compound in a 28% yield as a white
foamy solid. Rf 5 0.42 (n-Hex/AcOEt 7:3). 1H NMR
(202.4 MHz, CDCl3): d 5 8 (d, JP-H 5 744 Hz, 1 P, PH)
ppm. 19F NMR (470.5 MHz, CDCl3): d 5 262.9 ppm.
1
Phosphite (10). The general procedure was followed
to provide the title compound in a 55% yield as a off-white
foamy solid. Rf 5 0.43 (n-Hex/AcOEt 8:2). 1H NMR
(500 MHz, CDCl3): d 5 7.92–6.45 (d, JP-H 5 735 Hz, 1 H,
PH), 7.61 (d, 1J 5 8.2 Hz, 3 H, 3-H, m0-aryl H), 7.48 (t, 1J 5
1
7.7 Hz, 1 H, 4-H), 7.43 (d, J 5 8.4 Hz, 2 H, m-aryl H),
1
1
7.41–7.39 (m, 4 H, 3-H, 5-H, o0-aryl H), 7.31 (t, J 5 7.7 Hz,
(500 MHz, CDCl3): d 5 7.88–6.4 (d, JP-H 5 740 Hz, 1 H,
PH), 7.88 (s, 1 H, p-aryl H), 7.85 (s, 1 H, p0-aryl H), 7.76
(s, 4 H, o,o0-aryl H), 7.52 (d, 1J 5 7.85 Hz, 2 H, 5,50-H), 7.47
1
1
1 H, 40-H), 7.09 (d, J 5 7.6 Hz, 1 H, 30-H), 7.03 (d, J 5
1
7.5 Hz, 1 H, 50-H), 6.97 (d, J 5 8.3 Hz, 2 H, o-aryl H), 6.57
1
1
(t, J 5 7.7 Hz, 1 H, 4-H), 7.41 (t, J 5 7.7 Hz, 1 H, 40-H),
3
3
(dbr, JH-P 5 3.9 Hz, 1 H, CHOP), 6.2 (d, JH-P 5 8.5 Hz, 1
H, CH0OP0), 2.0 (s, 3 H, 2-CH3), 0.99 (s, 3 H, 20-CH3) ppm.
13C NMR (125 MHz, CDCl3): d 5 143.75 (d, 3JC-P 5 10 Hz,
7.24 (d, 1J 5 7.1 Hz, 1 H, 3-H), 6.94 (d, 1J 5 7.7 Hz, 1 H, 30-
3
3
H), 6.42 (d, JH-P 5 10.7 Hz, 1 H, CHOP), 6.0 (d, JH-P
5
6.0 Hz, 1 H, CH0OP0), 2.18 (s, 3 H, 20CH3), 2.17 (s, 3 H,
2-CH3) ppm. 13C NMR (125 MHz, CDCl3): d 5 142.4
3
C aryl0-CH0), 142.5 (d, JC-P 5 10 Hz, C aryl-CH), 138.95
(2 C, 2,20-C), 138.2 (6-C), 137.8 (10-C), 137.15 (60-C), 136
(1-C), 131.3 (5-C), 130.6 (50-C), 129 (m, 2 C, p,p0-aryl C),
128.7 (4-C), 128.5 (40-C), 128.3 (3-C), 126.5 (30-C), 126.3
(2 C, o0-aryl C), 125.7 (2 C, o-aryl C), 125.2 (2 C, m0-aryl
3
(d, JC-P 5 11 Hz, C aryl-CH), 141.8 (C aryl0-CH0), 138.2
(10-C), 137.4 (2-C), 137.3 (6-C), 136.9 (20-C), 136.8 (60-C),
2
136.5 (1-C), 132.4 (5-C), 132.25 (50-C), 132 (q, JC-F
5
32 Hz, 4 C, m,m0-aryl C), 129.8 (4-C), 129.5 (40-C), 128.1 (3-
C), 127.3 (30-C), 126.1 (2 C, o0-aryl C), 125.8 (2 C, o-aryl C),
1
C), 124.7 (2 C, m-aryl C), 124 (q, JC-F 5 270 Hz, 2 C, CF3,
C0F3), 81 (CHOP), 74.3 (C0HOP0), 19.9 (2-CH3), 18.5 (20-
CH3) ppm. 31P NMR (202.4 MHz, CDCl3): d 5 7.33 ppm.
19F NMR (470.5 MHz, CDCl3): d 5 262.5 ppm.
1
123 (q, JC-F 5 270 Hz, 4 C, CF3, C0F3), 122.1 (p0-aryl C),
122 (p-aryl C), 76.8 (CHOP), 74.84 (C0HOP0), 20.4 (2-CH3),
20 (20-CH3) ppm. 31P (121.4 MHz, CDCl3): d 5 7.96 ppm.
Phosphite (4). The general procedure was followed
to provide the title compound in a 45% yield as a white
foamy solid. Rf 5 0.5 (n-Hex/AcOEt 7:3). 1H NMR
General Procedure for the Synthesis
of Phosphoric Acids
1
(300 MHz, CDCl3): d 5 8.24–5.28 (d, JP-H 5 721 Hz, 1 H,
In a round-bottom flask, the corresponding phosphite
(1.0 mmol) was dissolved in Pyridine/H2O (4.5 ml, 9:1
ratio). I2 (3.0 mmol) was added. The dark purple solution
was stirred at room temperature for 2 h and thereafter
quenched with a saturated solution of Na2SO3 until the
reaction became pale yellow. The reaction was diluted
with AcOEt (4 ml) and the layers were separated. The or-
ganic layer was acidified to pH 1 with a 1 M solution of
HCl. The organic phases were dried with Na2SO4, filtered,
and the solvent was removed in vacuo. The product was
obtained without further purification.
1
PH), 7.67 (d, J 5 8.3 Hz, 4 H, m,m0-aryl H), 7.47 (m, 6 H,
5,50-H, o,o0-aryl H), 7.44–7.40 (m, 2 H, 4,40-H), 7.25 (d, 1J 5
1
7.4 Hz, 1 H, 30-H), 7.08 (d, J 5 7.6 Hz, 1 H, 3-H), 6.33 (d,
3
3JH-P 5 9.8 Hz, 1 H, CHOP), 6.0 (d, JH-P 5 8.1 Hz, 1 H,
CH0OP0), 2.18 (s, 3 H, 20-CH3), 2.17 (s, 3 H, 2-CH3) ppm.
3
13C NMR (75 MHz, CDCl3): d 5 143.5 (d, JC-P 5 10 Hz,
3
C aryl0-CH0), 142.9 (d, JC-P 5 10 Hz, C aryl-CH), 138.1 (6-
C), 137.8 (10-C), 137.3 (1-C), 137 (60-C), 136.8 (2-C), 136.3
(20-C), 131.6 (50-C), 131.5 (5-C), 130.3 (m, 2 C, p,p0-aryl C),
129.1 (40-C), 129 (4-C), 127.8 (30-C), 127.2 (3-C), 126.2
(2 C, o-aryl C), 125.9 (2 C, o0-aryl C), 125.3 (4 C, m,m0-aryl
1
Phosphoric acid (5). The general procedure was fol-
lowed to provide the title compound in a 90% yield as a
white solid. mp 224–2258C. [a]2D5 5 269.07 (c 5 0.197,
CHCl3). IR (CH2Cl2): m 5 1621, 1413, 1325, 1264, 1008
C), 124 (q, JC-F 5 260 Hz, 2 C, CF3, C0F3), 77.4 (C0HOP0),
75.4 (CHOP), 20.2 (2 C, 2,20-CH3) ppm. 31P NMR (121.4
MHz, CDCl3): d 5 8.28 ppm.
Phosphite (9). The general procedure was followed cm21
.
1H NMR (300 MHz, CDCl3): d 5 7.75 (sbr, 1 H,
1
to provide the title compound in a 31% yield as a white OH), 7.47 (d, J 5 8.1 Hz, 2 H, m0-aryl H), 7.39 (m, 3 H,
1
foamy solid. Rf 5 0.33 (n-Hex/AcOEt 8:2). H NMR (500 3,4,5-H), 7.33 (m, 4 H, o0-aryl H, m-aryl H), 7.24 (t, 1J 5 7.7
1
1
MHz, CDCl3): d 5 7.99–6.49 (d, JP-H 5 745 Hz, 1 H, PH), Hz, 1 H, 40-H), 6.98 (m, 2 H, 30-H, 50-H), 6.82 (d, J 5 7.8
7.83 (s, 1 H, p0-aryl H), 7.76 (s, 1 H, p-aryl H), 7.71 (s, 2 H, Hz, 2 H, o-aryl H), 6.3 (d, 3JH-P 5 3.7 Hz, 1 H, CHOP), 5.81
1
1
o0-aryl H), 7.64 (d, J 5 7.5 Hz, 1 H, 3-H), 7.52 (t, J 5 (d, 3JH-P 5 7.9 Hz, 1 H, CH0OP0), 2 (s, 3 H, 2-CH3), 0.92 (s,
7.5 Hz, 1 H, 4-H), 7.46 (d, J 5 7.5 Hz, 1 H, 5-H), 7.36 (d, 3 H, 20-CH3) ppm. 13C NMR (75 MHz, CDCl3): d 5 144 (d,
1
1J 5 7.75 Hz, 1 H, 40-H), 7.25 (s, 2 H, o-aryl H), 7.06 (d, 3JC-P 5 15 Hz, C aryl0-CH0), 142.6 (d, JC-P 5 15 Hz, C aryl-
3
1J 5 7 Hz, 1 H, 30-H), 7.04 (d, J 5 7 Hz, 1 H, 50-H), 6.57 CH), 138.5 (2-C), 138.3 (20-C), 138.1 (6-C), 138 (10-C),
1
3
(sbr, 1 H, CHOP), 6.23 (d, JH-P 5 8.5 Hz, CH0OP0), 2.02 136.7 (60-C), 136.2 (1-C), 131 (5-C), 130.3 (50-C), 129 (m, 2
(s, 3 H, 2-CH3), 0.97 (s, 3 H, 20-CH3) ppm. 13C NMR C, p,p0-aryl C), 128.6 (4-C), 128.4 (40-C), 128.1 (3-C), 126.7
Chirality DOI 10.1002/chir